Hope for reducing the cardiovascular complications associated with dialysis

Biotech companies Invizius and 3P Biopharmaceuticals collaborate on an innovative technology for patients undergoing hemodialysis and suffering from cardiovascular disease. Invizius, a Scottish biotech company and 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, have initiated a collaboration on an innovative treatment for reducing […]